Investing Ideas
/
French Biotech Breakthroughs

French Biotech Breakthroughs

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

1 companies

DBV Technologies

Market Cap: €1.0b

A clinical-stage biopharmaceutical company, engages in the research and development of epicutaneous immunotherapy products in France.

DBV

€3.64

3.3%

183.1%